View Item 

Compatibility of pentoxifylline and parenteral medications

Access Status
Fulltext not available
Authors
Campbell, A.L.
Petrovski, M.
Senarathna, S.G.
Mukadam, N.
Strunk, T.
Batty, Kevin
Date
2020
Type
Journal Article

Metadata
Show full item record
Citation
Campbell, A.L. and Petrovski, M. and Senarathna, S.G. and Mukadam, N. and Strunk, T. and Batty, K.T. 2020. Compatibility of pentoxifylline and parenteral medications. Archives of Disease in Childhood. 105 (4): pp. 395-397.
Source Title
Archives of Disease in Childhood
DOI
ISSN
Faculty
Faculty of Health Sciences
School
Curtin Medical School
URI
Collection
Abstract

Objective: To investigate the physical and chemical compatibility of pentoxifylline (PTX) with a range of parenteral medications used in neonatal intensive care.

Design: PTX and drug solutions were combined in glass vials, inspected for physical incompatibility and evaluated on the basis of PTX concentrations for chemical compatibility.

Results: No precipitation, colour change or turbidity was observed in any of the test mixtures. The PTX concentration was approximately 5.5% lower when combined with undiluted calcium gluconate injection (100 mg/mL). The PTX concentration ratios for all other combinations, including diluted calcium gluconate injection (50 mg/mL), were in the range of 99.5%-102%.

Conclusion: In simulated Y-site conditions, PTX was found to be compatible with 15 parenteral medications and six total parenteral nutrition solutions. Based on PTX concentration tests, it would be prudent to avoid mixing PTX with undiluted calcium gluconate injection.